WELCOME TO THE NEW ENDOCINCH WEBSITE!


July 10, 2002 -- This site has been designed to educate patients and health care professionals about the exciting advantages of the EndoCinch procedure. The EndoCinch site re-design will allow web users the ability to view an EndoCinch procedure, compelling clinical data, patient testimonial as well as locate a local practicing EndoCinch physician. This site will also house a library containing clinical reference and other invaluable material for clinicians.

About C. R. Bard, Inc.

C. R. Bard, Inc., headquartered in Murray Hill, New Jersey, is a leading multinational developer, manufacturer and marketer of healthcare products. Bard Endoscopic Technologies, headquartered in Billerica, MA, is a division of C. R. Bard, Inc. (NYSE-BCR), specializing in the field of gastroenterology. For more than ten years, Bard Endoscopic Technologies (formerly Bard Interventional Products) has been developing minimally invasive diagnostic and therapeutic products used in conjunction with procedures requiring flexible endoscopy. Visit the company website at www.crbard.com.

View all press releases

EndoCinch Home :: Patient Center :: Doctor Center :: Press Releases
About EndoCinch/CR Bard :: Clinical Support :: Contact Us :: Site Map :: Privacy Policy :: Terms of Use
1-800-556-6275

© 2005 C.R. Bard. All rights reserved. Davol Inc. is a subsidiary of C.R. Bard, Inc. or an affiliate.
* Bard and Davol are registered trademarks and EndoCinch is a trademark of C.R. Bard, Inc. or an affiliate.

This site is not intended as a substitute for professional medical care. Only your physician can diagnose and appropriately treat your symptoms.

Please consult product labeling and instructions for use for all indications, contraindications, warnings, precautions and directions for use.